West Pharmaceutical Services, Inc. (WST) Q2 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

to the Q2 2025 West Pharmaceutical Services Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during the session, you will need to press star 1-1 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press star 1-1 again. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, John Sweeney, Head of Investor Relations. Please go ahead. Good morning and welcome to West's second quarter 2025 earnings conference call. We issued our financial results earlier this morning and the release has been posted in the investor section of the company's website located at westpharma.com. On the call today, we will review our financial results, provide an update for our business, and our outlook for FY25. There's a slide presentation that accompanies today's call, and a copy of the presentation is available on the investor page of West's website. On slide four is the safe harbor statement. Statements made by management on the call and the accompanying presentation contain forward-looking statements with the meaning of U.S. federal securities law. These statements are based on our beliefs and assumptions, current expectations, estimates, and forecasts. The company's future results are influenced by many factors beyond the control of the company. Actual results could differ materially from past results, as well as those expressed or implied in any forward-looking statements made here. Please refer to today's press release, as well as other disclosures made by the company regarding the risks to which this subject, incl...